CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumor
Science Advances · 21.03.2025 · 11 (12)
DOI: 10.1126/sciadv.adt2117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 21.03.2025. Verfasst von Ishita Sarkar und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Biology and Inflammatory Disorder, IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolk…. Hauptthemen laut MEDLINE: ADP-ribosyl Cyclase 1, T-Lymphocytes, Regulatory, Membrane Glycoproteins, Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, DBT-Wellcome Trust India Alliance.
Abstract (Originalsprache)
In the tumor microenvironment (TME), regulatory T cells (T regs ) adapt their metabolism to thrive in low-glucose, high-lactate conditions, but the mechanisms remain unclear. Our study identifies CD38 as a key regulator of this adaptation by depleting nicotinamide adenine dinucleotide (oxidized form) (NAD + ), redirecting lactate-derived pyruvate toward phosphoenolpyruvate and bypassing the tricarboxylic acid (TCA) cycle. This prevents accumulation of α-ketoglutarate, which destabilizes T regs by inducing hypermethylation at the Foxp3 locus. Restoring NAD + with nicotinamide mononucleotide reverses this adaptation, pushing T regs back to the TCA cycle and reducing their suppressive function. In YUMM1.7 melanoma-bearing mice, small-molecule CD38 inhibition selectively destabilizes intratumoral T regs , sparking robust antitumor immunity. These findings reveal that targeting the CD38-NAD + axis disrupts T regs metabolic adaptation and offers a strategy to enhance antitumor responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Cancer Biology and Inflammatory Disorder, IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, India.
- Institute for Bioinformatics and Medical Informatics, University of Tübingen, Sand 14, 72076 Tübingen, Germany.
- International Max Planck Research School "From Molecules to Organisms", Max Planck Institute for Biology Tübingen, Max-Planck-Ring 5, 72076, Tübingen, Germany.
- CSIR-Institute of Genomics and Integrative Biology, New Delhi 110020, India.
- Division of Infectious Disease and Immunology, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, India.
ORCID-Profile: Ishita Sarkar, Puspendu Ghosh, Anupam Gautam, Shaun Mahanti, Snehanshu Chowdhury, Soumya Mondal, Ramanuj Mukherjee, Shikhar Mehrotra, Shantanu Sengupta, Sandip Paul, Shilpak Chatterjee
Förderung
- Wellcome Trust
- DBT-Wellcome Trust India Alliance
Zitieren
APA
Sarkar, I., Basak, D., Ghosh, P., Gautam, A., Bhoumik, A., Singh, P., Kar, A., Mahanti, S., Chowdhury, S., Chakraborty, L., Mondal, S., Mukherjee, R., Mehrotra, S., Majumder, S., Sengupta, S., Paul, S., & Chatterjee, S. (2025). CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumor. Science Advances, 11(12). https://doi.org/10.1126/sciadv.adt2117
Vancouver
Sarkar I, Basak D, Ghosh P, Gautam A, Bhoumik A, Singh P, et al. CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumor. Science Advances. 2025;11(12). doi:10.1126/sciadv.adt2117
BibTeX
@article{Sarkar2025,
author = {Sarkar, Ishita and Basak, Debashree and Ghosh, Puspendu and Gautam, Anupam and Bhoumik, Arpita and Singh, Praveen and Kar, Anwesha and Mahanti, Shaun and Chowdhury, Snehanshu and Chakraborty, Lagnajita and Mondal, Soumya and Mukherjee, Ramanuj and Mehrotra, Shikhar and Majumder, Saikat and Sengupta, Shantanu and Paul, Sandip and Chatterjee, Shilpak},
title = {CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumor},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {12},
doi = {10.1126/sciadv.adt2117}
}
EUVIMED